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The Compression of Morbidity hypothesis, positing that the age of onset of chronic illness may be postponed more than the
age at death, squeezing most of the morbidity in life into a shorter period with less lifetime disability, was introduced by
our group in 1980. This review is focused upon the evolution of the concept, the controversies and responses, the supportive
multidisciplinary science, and the evolving lines of evidence that establish proof of concept. We summarize data from 20-year
prospective longitudinal studies of lifestyle progression of disability, national population studies of trends in disability, and
randomized controlled trials of risk factor reduction with life-style-based “healthy aging” interventions. From the perspective
of this inﬂuential and broadly-cited paradigm we review its current history, the development of a theoretical structure for healthy
aging, and the challenges to develop coherent health policies directed at reduction in morbidity.
1.Introduction
The Compression of Morbidity paradigm was introduced
as a hypothesis of healthy aging in 1980 [1]. It was a
counterpoint to the then prevalent paradigm of the “Failures
ofSuccess”[2],whicharguedthatincreasinglifeexpectancies
would lead inevitably to additional years of chronic debili-
tating illness, economic collapse, and increasing misery for
many seniors. In its simplest form, the new thesis was that
“theageatﬁrstappearanceofsymptomsofagingandchronic
disease can increase more rapidly than life expectancy.” Since
most of the morbidity, disability, frailty, inﬁrmity, decreased
health-related quality-of-life, medical care costs and other
descriptors of ill health (considered here as synonymous)
occur later in life and are bounded at the lower end by their
age at onset and at the upper end by the age at death; a
more rapid rise in the age at ﬁrst chronic inﬁrmity than in
the age at death would squeeze total lifetime morbidity into
a shorter span, and thus reduce inﬁrmity [3]. The health
strategies necessary to attain morbidity compression, it was
conjectured, would be based largely on postponement of ill-
health by prevention of chronic disease [4–6].
Figure 1 extends a common representation of the com-
pression of morbidity [4]. Present lifetime morbidity is
contrasted with two of many alternate scenarios, one of
life extension and one of morbidity compression. Disabil-
ity/morbidity in the senior years is displayed as having an
initialappearanceinlatermiddleage,andtoincreaselinearly
over time until death, with lifetime morbidity represented by
the area of the triangle.
Of course, reality is never so uncomplicated. Displayed
at the bottom of the ﬁgure are a few of the many possible
individuallifecoursetrajectorieswhichcombinetorepresent
population aging [7]. Compression of Morbidity trajectories
range from the fatal ﬁrst heart attack at age 50 (early
mortality, minimal morbidity) to the spry 95-year old
woman dying asymptomatically in her sleep (late mortality,
minimal morbidity).
An assumption of steady linear decline in function also
is too simplistic. There can be recoveries from serious
impairments and relapses from successful treatments [8].
Population health over time is a sum of the positive and
negative morbidity trajectories of the individuals in the
population. We can measure the algebraic sum but not
yet the individual trajectories. Trajectories with the greatest
cumulative morbidity tend toward early onset intractable
morbidity with long periods of limited function, as with
the 20-year-old quadriplegic. We remain in the early days2 Journal of Aging Research
Birth Death
Morbidity onset
Present morbidity
Compression of morbidity
Life extension
Low morbidity Exponential Front-loaded Multi-phasic
Low, short Expo, short Front, short Multi, short
Birth
Birth
Death
Death
Morbidity onset
Morbidity onset
Figure 1: Scenarios for future morbidity. The three major popula-
tion scenarios in the upper part of the ﬁgure represent (1) depiction
of a present health, (2) a future where both life expectancy and
morbidity are both increased, and (3) a future where both the
time period after ﬁrst morbidity and the amount of morbidity
are decreased, resulting in Compression of Morbidity. Shaded
areas represent under the curve cumulative morbidity. In the
Compression of Morbidity scenario, lifetime disability is decreased.
National disability trends over time are the algebraic sum of the
eight individual trajectories illustrated at the bottom of the ﬁgure
and many more. Some individual scenarios may add morbidity
to a population average and some may subtract from it. The area
under the morbidity curve is a useful metric for population health
or health-related quality-of-life. The variables that aﬀect the area
under the curve are many and complex and have not yet been well
delineated (see text).
of trying to categorize and quantitate the eﬀects of diﬀerent
trajectories of morbidity [7].
A variety of misunderstandings of the compression
of morbidity hypothesis characterized the early years of
the paradigm. These were inﬂuenced by concerns that
emphasis on prevention would stiﬂe research in the sciences
of aging, that the necessary infrastructure for care of
increasing numbers of seniors might not be forthcoming,
that demographic projections embarrassingly might require
revision, that funding might shift away from technology and
specialized care, and that the eventual ultimate achievement
of immortality was rendered more suspect [8–15]. Looking
backatthesecriticisms,oftenoﬀeredforcefully,thereseemsa
tendency toward protection of self-interests. A problem with
projections of morbidity at that time, of course, was that
there were no data at all on trends in disability over time,
let alone diﬀerent trends over time for diﬀerent population
subgroups.
Some speciﬁc misunderstandings centered around
whether the human life span is ﬁxed and whether compres-
sion of morbidity in the future was certain [10]. To set these
distractions to rest, compression of morbidity is clearly
not inevitable, as has been shown in the Eastern European
experience, in many third world countries, and in segments
of populations in the developed world. Similarly, average life
expectancy from birth, and even from age 65, is expected to
continue to increase for many years by almost all observers,
including ourselves. Since any limits would be approached
asymptotically, any limit would never actually be reached.
Further, there will be many more seniors in future developed
populations by any computation; these numbers are driven
predominately by increasing birth cohorts, in-migration,
and increased rates of survival to age 65. Only about 5% of
population increases in those over 65 years of age over the
next 20 years will be due to 65 year olds living 20 more years
rather than 19 [16]. Moreover, increases in life expectancy
do not need to slow or to stop for compression of morbidity
to occur [17]. Rather, it is the relative rate of increase in
morbidity rates and in mortality rates that is the important
metric.
Reduction in lifetime morbidity through postponement
involves four strategies, not only the strategy of primary pre-
vention: (1) “Primordial” Prevention prevents the risk factor
(not the illness) from developing. For instance, decreasing
the number of teenagers who start smoking or preventing
childhood obesity represents primordial prevention; (2)
Primary Prevention decreases risk factor prevalence, as by
stopping smoking, promoting exercise, reducing weight, and
reducing hypertension and cholesterol levels; (3) Secondary
Prevention is aimed at preventing progression of disease, as
in decreasing second heart attacks, congestive heart failure,
or complications of diabetes; (4) Tertiary Prevention aims
at reduction of morbid states that have already occurred,
as with replacement of faulty hips, failed kidneys or livers,
or use of a scooter for locomotion. Tertiary Prevention
can reduce morbidity but often does not eliminate it.
A strategic approach to reduction in lifetime morbidity
requires all four approaches and requires that technological
inputs from statins for prevention of heart attacks to cataract
extraction be included and their positive and negative eﬀects
assessed.
Controversy over the Compression of Morbidity hypoth-
esis began to moderate as the large National Long-Term Care
Survey and the National Health Interview Survey begun in
1982 largely to answer issues about longitudinal trends in
senior health, began to generate data. At the same time,
former critics of the Compression Hypothesis began to
espouse “Healthy Aging” programs built around exercise
and reducing health risks, recognizing that the “Failures
of Success concept” [9, 12] had been actually espousing
“unhealthy aging,” an awkward position for a gerontologist.
Of course apologists for older concepts are still around
[18], in part a dispute remains because of confusion about
the metrics of morbidity. This paper is termed “focused”
since it is concerned with the evolution of a new paradigm
and attempts not to directly criticize those who historically
impeded this evolution.Journal of Aging Research 3
2. Metrics of Morbidity
“Mortality” is conceptually clear. However, dictionaries do
not agree on the deﬁnition of morbidity. At one pole is
a premise that morbidity is a broad concept including
everything that detracts from health-related quality of life
or adds to ill-health or frailty [14]. At the other pole,
morbidity is held erroneously to be the number of diagnoses
or the number of chronic conditions for an individual.
The problems of deﬁning morbidity as a simple count of
chronic conditions are easily understood; diagnoses span
a broad range of morbidity, from none to incapacitating.
Diabetes can be an abnormal blood test or a devastating
disease; cancer can be presumably eradicated only to return
after years. The diagnostic label has little directly to do
withquantitationofmorbidity.Moreover,“chronicillnesses”
such as osteoporosis, hypertension, or hyperlipidemia are
oftennotmorbidconditions.Diagnosis-countingmetricsare
a metric of convenience, since these data are incidentally
captured by many secondary data sources. Secondary data
sources,unfortunately,seldomincludeeverythingdesiredfor
a study. Use of diagnosis-counting metrics has not correlated
consistently with morbidity as deﬁned within a disability or
frailty framework [19–21].
The more useful metric deﬁnes the “latent trait” of
morbidity as a broad form of disability, frailty, impairment
of functioning at activities of daily living (ADL), or other
decrease in health-related quality of life. The most common
outcome instruments use functional disability as a proxy for
morbidity [19, 21, 22]. Even here, most disability scales do
not include disability related to vision, hearing, cognition,
or psychological distress [23] and hence are conceptually
incomplete. The disability proxy, however, can be argued to
(1) include much of the morbidity latent trait, (2) be reliably
measurable by patient self-report, (3) be a continuous
variable permitting sensitive measurement of change and
longitudinal study, (4) be consistent with patient concepts
of ill-health, and (5) be correlated with global health
measures and other measures of physical function [23–
28]. Longitudinal study with disability or physical function
measures of morbidity in seniors now exceeds 20 years in
some instances, as discussed below.
3.Mortality
Mortality changes can be tracked with acceptable accuracy
using the Vital Statistics of the United States or other sources
[16]. Figure 2 summarizes the US data since 1900, which is
generally similar to that of other developed nations. All mea-
suresoflongevityincreasemonotonicallyforalmostallyears,
providing periodic headlines and prophecies of impending
crises.Therealmessage,however,isthatlongevitygainsfrom
age 65 and above are quite slow and probably getting slower.
Curves of expected ages at death calculated from birth
and from age 65 (Figure 2) converge slowly and would
eventually meet if there were zero deaths under age 65; the
curves mathematically cannot cross unless there are fewer
than no deaths under age 65, a mathematical impossibility
[1, 6, 16]. Estimates of the rate of convergence vary with the
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Figure 2: US expected age at death from birth and from age 65,
1950–2007. The lower line shows life expectancy from birth, rising
9.7 years over this period. The upper line takes life expectancy from
age 65 and adds 65 years to represent the expected age at death for
those who have already survived to age 65; it rises 4.7 years over
thisperiod.Thelines,whileconvergent,cannotactuallymeetunless
there are no deaths before age 65. The lines cannot cross; hence the
theoretical point of convergent is sometimes termed the “Point of
Paradox”.
base period used for extrapolation; more recent base periods
project more distant and higher “Points of Paradox”, where
the curves are projected to cross. These curves have been
ﬂattening slightly in recent decades, particularly in white
females. Women always outlive men, minorities lag; full data
are available at the original sources [6, 16].
Table 1 shows the average number of years of life remain-
ing from 1900 to 2007 from various ages, combining
both sexes and ethnic groups. From birth, life expectancy
increased from 49.2 years (previously estimated at 47.3
years in these same sources) in 1900 to 77.9 in 2007, a
gain of life expectancy of nearly 29 years and a prodigious
accomplishment. The increase was largely due to declines
in perinatal mortality and reduction in infectious diseases
which aﬀected mainly younger persons. Over this period,
developed nations moved from an era of acute infectious
disease to one dominated by chronic illness. As a result, life
extension from age 65 was increased only 6 years over the
entire 20th century; from age 75 gains were only 4.2 years,
from age 85 only 2.3 years and from age 100 a single year.
From age 65 over the most recent 20 years, the gain has been
about a year [16].
Much confusion in longevity predictions comes from
using projections of life expectancy at birth to estimate
future population longevity [18]. For example, “If the pace
of increase in life expectancy (from birth) for developed
countries over the past two centuries continues through the
21st century, most babies born since 2000 will celebrate their
100th birthdays” [29]. Note from the 100-year line of Table 1
that life expectancies for centenarians would be projected
to rise only one year in the 21st century, as in the 20th.
Such attention-grabbing statements follow from projecting
from birth rather than age 65, thus including infant and
early life events to project “senior” aging, using data from
women rather than both genders combined, cherry-picking
the best data for each year, neglecting to compute eﬀects of
in-migration and out-migration, and others.4 Journal of Aging Research
Table 1: US life expectancy 1900–2007 from various ages. Average number of years of life remaining.
From age 1900 1920 1940 1960 1980 2000 2007 Gain, Years 1900–2007
0 49.2 65.4 63.6 69.9 73.9 76.9 77.9 28.7
65 11.9 12.5 12.8 14.4 16.5 17.9 18.6 6.7
75 7.1 7.5 7.6 8.7 10.5 11.3 11.7 4.6
85 4.0 4.2 4.3 4.6 6.0 6.3 n/a 2.3
100 1.6 1.5 2.1 1.9 2.7 2.6 n/a 1.0
Some variant predictions have used “cohort” life tables
projected into the future to compare with the “period” life
tablesthatareusedtraditionallytocomparelifeexpectancies.
Cohort life tables take a cohort, such as the year 2000,
and follow those individuals forward until they have died,
p e r h a p sac e n t u r yf r o mn o w .C o h o r tl i f et a b l e su s u a l l yr e s u l t
in lower mortality rates.
Another age exaggeration tactic is to confuse the old-
est age obtained with the maximal possible average life
expectancy of a population (life span). The ﬁrst is estimated
variously as from 114 to 122 years, the second is perhaps 90
years, at least in this century. Surprisingly, little is learned
about a population from its outliers; it is interesting to know
the height of the tallest man but it conveys little information
about human stature. We believe the population life span
(maximal average life expectancy) is the most informative
perspective from which to assess human aging.
The major trespasses are using the 200-year base rather
than the last quarter century and the failure to limit
study to seniors by basing projections on life expectancy
from birth. Of more than peripheral interest here is that
proposed revisions of pension systems by increasing the age
of eligibility always use the wrong metric, life expectancy
from birth.
Table 2 projects future decedent ages using base rates
from 1900 through 2007 (the latest year available at this
writing) and a shorter current period, 1980 to 2007, to
explore the role of base period in projecting future mortality
rates [1, 16]. The computation is straightforward. First,
obtain life expectancy values for the base year and last
available year, both from birth and from age 65. Second,
calculate the average increase in life expectancy per year for
each base period and from birth and age 65. Then solve
the equations for the Point of Paradox, which identiﬁes the
Point at which life expectancy from birth, rising at its rate, is
equal to expectancy age from age 65, rising at its slower rate.
Over the 107-year base period, the increase in life expectancy
from birth over that from age 65 is approximately fourfold;
over the 27-year base, it is less than twofold, documenting
a ﬂattening of the rate of increase in more recent periods
(in the US). The “Point of Paradox” is the point at which
the converging lines would cross. With the 107-year base, the
Point of Paradox occurs in 2035 at an average age of 85.4.
This projection, with the long base period, has changed
little since we ﬁrst made this computation in 1980 [1]. On
theotherhand,withthemorerecentbaseperiodtheParadox
occurs in the year 2083 at an average age of 89.8 years. These
ages represent an estimation of a maximal attainable average
age at death. Given that past trends continue and that no dire
disaster nor scientiﬁc elixir bends the trend lines. Figure 2
provides some reassurance that this is not an unreasonable
assumption, showing stable trends over very long periods.
Since the Point of Paradox cannot be reached, the future
curve will of necessity move toward an asymptote below
the upper trend line and to a point more distant in the
future.Theseandallotherprojectionsoffuturemortalityare
estimates.
Since 1980 [1], we have performed similar calculations
using data from many nations and many baseline periods
andfromdiﬀerentages,withcongruentresults.Themaximal
average age ranges from 85 to about 93 years, with later base
periods tending to be higher, and Japan and several other
countrieshigherthantheUSWeestimatedtheUSmaximum
average life expectancy at 85 years in 1980, and now at 90
years.USWhitefemalescurrentlyprojectto90.1years.Thus,
given generally stable trends, the maximal attainable mean
life expectancy appears to be greater than 90 years and is
almost certainly less than 100, far less than the 150 to 200
years still projected by some enthusiasts [29].
These projections hold over a broad range of technical
assumptions. The base trend line for these calculations is
always life expectancy from birth since this is a coherent
place to start and provides the greatest statistical diﬀerence
in rates. The comparator trend line is most reasonably set at
life expectancy from age 65, the traditional age of seniority,
for which data are widely available. This age represents for
many the boundary between adult life and senior life and is
the age at which many senior ﬁnancial beneﬁts accrue. Since
the Point of Paradox occurs at the point where there are no
deaths before that age, age 65 works quite reasonably with
this assumption since 90 percent of a number of populations
already live to age 65. If the comparison age is set lower,
such as 55 or 45, the Paradox is reached earlier at a lower
age and may actually be below ages already achieved in some
populations. If set higher, such as 90 or 100, the Point of
Paradox, which cannot be below the top trend line, will be at
that number, but not for millennia. Setting the comparison
trend from age 75 or 85 gives results similar to 65, a little
higher and considerably farther in the future. We believe
that the Point of Paradox gives reasonable and transparent
estimates for maximal attainable average life expectancy, and
that the projections published over 30 years ago remain
current today. All estimates by any method, however, are
subject to change, and conﬁdence in any estimate should be
considered in terms of how many years forward are being
extrapolated.Journal of Aging Research 5
Table 2: US expected age at death projected from life expectancy data 1900–2007. Projecting future mortality ages: US, all races, both sexes,
data 1900–2007 and 1980–2007.
From birth From age 65
Ages at death
(1900) 49.2 76.9
(1980) 73.7 81.4
(2007) 77.9 83.6
Increase
(Years: 1900–2007) 28.7 6.7
(Years: 1980–2007) 4.2 2.2
Increase/year
(107 years: 1900–2007) 0.268 0.063
(27 years: 1980–2007) 0.156 0.081
Point (Year) of Paradox (where ages of death from birth and from age 65 would be the same) (X = Years to Paradox)
(Projecting from 1900–2007 data—107 years) 85.4 85.4 (2035)
77.9 + 0.268(X) = 83.6 + 0.063(X), P = 2007 + (28 years to Paradox [P])
(Projecting from 1980–2007 data—27 years) 89.8 89.8 (2083)
77.9 + 0.156(X) = 83.6 + 0.081(X), P = 2007 + 76 years
The preceding discussions do not bear directly on the
major theme of this paper and discussion of the limits, ﬁxed
or not, of life expectancy has been inﬂammatory and a taboo
area for some persons and may have diverted some from
consideringthecentralthemeofpostponementofmorbidity.
Yet, since the media and the public still are intrigued by
the extravagant assumptions, the points made above remain
important.
Most importantly, the Compression of Morbidity para-
digm does not depend upon whether the human life span is
ﬁxed or rising. It depends on relative changes in mortality
rates and in morbidity/disability rates [6]. Compression of
Morbidity can occur with falling life expectancies, or with
rising ones [16].
4.Morbidity
Over the past 30 years, three major lines of evidence
supporting the Compression of Morbidity Paradigm have
emerged, and our research group has been involved in each.
First, we began longitudinal studies of disability in seniors
in 1984 and 1986 and are now publishing 20-year data on
progression of morbidity with age. Second, we encouraged
the creation and occasionally advised the National Long-
Term Survey and the National Health Interview Survey
Projects, examining national trends in the development of
senior morbidities. Third, we performed randomized trials
of health risk changes after healthy-aging interventions to
prove that risk factor reductions and health improvement
could be achieved in senior populations. These ﬁndings
provide proof of concept, that compression of morbidity
can occur in speciﬁc settings and at speciﬁc times. They do
not argue that morbidity compression is inevitable. They
do provide insight into approaches that might increase our
ability to reduce cumulative lifetime morbidity.
5. LongitudinalEpidemiologic Studiesof
LifestyleandSenior Morbidity
The University of Pennsylvania (UPenn) [30, 31] and the
Runners studies [32–34] have reported results periodically
and this paper presents an update of progress and ﬁndings in
thesestudies.Thesestudiessoughttodevelopdatatodirectly
support or refute the Compression of Morbidity hypothesis
by prospective longitudinal study of seniors progressing
into old age, with development of increasing disability over
time. A major prediction of the Compression hypothesis, of
course, is that seniors with healthier lifestyles will live longer
yet have less cumulative lifetime disability than those with
less healthy lifestyles.
Design of such studies contains multiple challenges not
the least of which are development of a dedicated and
competent staﬀ and collaborators and execution of a plan
for continuation of study funding over a very long time;
we are grateful for support from three NIH Institutes. The
scientiﬁc challenges of observational studies are to avoid
or control bias and confounding. Our largest concern was
about confounding by education, income, and occupation,
and associated eﬀects upon smoking, lack of exercise, and
obesity, our major lifestyle risks, as well as additional health
risks due to poverty, neighborhood, and lack of access to
medical care. Accordingly, we recruited populations with
favorable social and environmental factors, in part because
critics otherwise could suggest that we were just measuring
the well-established correlations between poverty and poor
health. The UPenn study (1986-) compared University of
Pennsylvania alumni from 1939-1940 with 0, 1, or 2 or 3
major health risks. The Runners Study (1984-) compared
runners and controls from a university community; both
groups were highly educated, lean, and contained few6 Journal of Aging Research
smokers. All data were primary data, collected as an a priori
test of the Compression of Morbidity hypothesis.
We followed all subjects yearly with the same protocols,
assessing disability with the Health Questionnaire [19, 21],
medical history, pain, patient global health, other covariates,
and X-rays of knees and hips in subgroups; these were
examined for associations with group membership and sta-
tistically adjusted when necessary. Women developed more
and earlier disability than men, and we repeated analyses
for each gender separately. Since some might have taken up
running only to discontinue prior to study enrollment, we
created secondary study groups of those who had ever run
for exercise for more than a month and those who had not
and repeated analyses for these “ever-runners” and “never-
runners”. Since disability incurred prior to study onset could
be important later on, we restricted some analyses to only
those cases or controls with zero disability at study onset.
All subjects were placed in the study groups at enrollment
and remained in the same group subsequently. Study drop-
outswerecomparedwiththosecontinuingandfoundtohave
similar characteristics.
6. Universityof PennsylvaniaStudy
In the University of Pennsylvania study [30, 31], we followed
2,327 alumni from an average age of 68, stratiﬁed at baseline
intolowrisk,moderaterisk,andhighriskgroupsbasedupon
0, 1, or 2 or 3 of the three major risk factors (obesity, lack of
exercise, smoking). Multivariable survival analyses examined
time to disability or death in each group. Postponement of
disability and mortality by group were calculated from linear
regressions over all data points. Results showed monotonic
increases in disability and cumulative disability over age in
all groups, with more severe disability (P<0.001) in those
with more baseline health risks (Figure 3). Findings were
conﬁrmed in men, women, those without initial disability,
survivors, and decedents (Figure 4). Disability at the 0.1
levelontheHealthAssessmentQuestionnairewaspostponed
8.3 years in the low risk groups and moderate disability
5.8 years when compared with the high risk group. Deaths
on the other hand were postponed on average only 3.6
to 3.9 years in low risk groups compared with moderate
and high risk groups. Results were conﬁrmed by survival
analysesadjustedforage,gender,andbaselinedisability[35].
Good health habits led to greatly increased functional ability,
decreased lifetime disability, and longer lives, with eﬀects on
morbidity greater than those upon mortality. Compression
of Morbidity occurred in the low risk group compared with
the high, even in these groups where all subjects were socially
advantaged.
7.RunnersStudy
The Runners Study [32–34] is designed to test the eﬀects of
regular, vigorous exercise upon morbidity and mortality in
seniors. The study was begun in 1984, and 21-year results
have been reported; the study was begun because although
many studies extol the health beneﬁts of exercise, few if any
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Figure 3: Development of disability with age in seniors after age
68 subjects with low (0), moderate (1) and high (2-3) risk factors
in 1986. The University of Pennsylvania Study, over 21 years,
has followed seniors from age 68 in three strata: Low Risk, with
no baseline risk factors of smoking, obesity, or lack of exercise;
Moderate Risk, where one risk factor was present at baseline,
and High Risk, where two or three risk factors were present at
baseline. The lower line represents low risk subjects, the middle
line moderate risk subjects, and the top line high risk subjects.
Diﬀerences are major whether looked at by vertical diﬀerences,
or by longitudinal ones (postponement). When contrasted with
mortality rates, Compression of Morbidity by health risk factor
status is demonstrated across these groups.
looked at long-term eﬀects of rigorous exercise in seniors
by prospective longitudinal study. The study was designed
as a direct test of the Compression of Morbidity hypothesis,
positing that exercising individuals, compared with controls,
would have prolonged lives but even greater postponement
of disability.
We compared 538 members of an over-50 running club
with 423 healthy controls also over age 50, beginning in
1984. We obtained radiographs of knees and hips on a
15% subsample of subjects at ﬁve-year intervals. Appro-
priate controls for selection bias were performed including
excluding those with baseline disability over zero, completers
versus noncompleters, men versus women, and statistical
adjustment for major potential confounders. At baseline,
Body Mass Index (BMI) diﬀered between groups (23.1
runners, 24.5 controls, both in desirable ranges), runners
were younger (58 years versus 63), and runners smoked
more rarely (2.1% to 12.9%). Time and cause of death
were ascertained from the National Death Index. Details are
provided in the original sources [32–34].
Disability was higher in controls throughout the study
and diﬀerences increased with age (Figure 5). Time to a
disability level of 0.15 was postponed 12 years in runners (7
years versus 19 years) representing a postponement of more
than a factor of two. Runners trended toward fewer knee and
hip replacements than controls (n.s.) [33].Journal of Aging Research 7
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Figure 4: Cumulative disability in seniors by risk groups. Lifetime
disability is estimated by summing disability reported from each
year for each subject, then averaging by risk group. Results are
consistent across men, women, all subjects, survivors, decedents,
thosewithnodisabilityatbaseline,andothersubgroupsatbaseline.
Greater numbers of risk factors are consistently associated with
much more cumulative lifetime disability, a surrogate metric for
Compression of Morbidity.
Time to death of the ﬁrst 10% of the sample was
postponed in runners by a factor of two (8 years to 16 years)
and to a mortality of 15% was postponed from 11.5 years to
19.5 years, less than double. These data are consistent with
a marked association of vigorous exercise with both reduced
disability and postponed death, with the eﬀect on morbidity
marginally greater than the eﬀect on mortality, arguing for
modest Compression of Morbidity.
8.US NationalDeclinesinDisabilityLevels
The National Long-Term Care Survey (NLTCS) (1982–2004)
[36, 37] and National Health Interview Study (NHIS)[20]
(1982–1999) are the premier long-term studies of disability
trends in the US The NLTCS samples Medicare eligible
subjects (n = 20,000 per wave) over 65 years of age, whether
institutionalized or community-living; the NHIS samples
noninstitutionalized individuals over age 70 (n = 8,000 per
wave).Bothshowdecliningdisabilityfrom1982to2004with
an increase in the rate of decline in more recent years. In
theNLTCS,minoritydeclines,whichhadlagged,alsoshowed
declines after 1999 [37, 38]. Of interest, an early critic of the
Compression of Morbidity Hypothesis, Kenneth Manton,
led the careful analyses and positive interpretations of the
NLTCS [37, 38].
Mortality rates over this entire period declined about 1%
a year; declines in “any disability” in the NLTCS averaged
1.27% over the entire period and 2.1% in the last ﬁve years
(Table 3)[ 37]. Thus, these studies document Compression
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Figure 5: Disability progression—ages 58–79 years: Runners’ Club
and Community Controls. Progression of disability in Runner’s
ClubandCommunityControlgroupsover21yearsfromanaverage
age of 58 is compared in the ﬁgure both with yearly disability values
and statistically derived regression lines. The regression lines are
derived from linear mixed models and adjusted for age, gender,
BMI, smoking, and initial disability. Comparison of postponement
of disability is represented by the absolute diﬀerence between the
twogroupsinthetimerequiredtodevelopagivenlevelofdisability.
The example shown is to reach Health Assessment Questionnaire
(HAQ)DisabilityIndexScoresof0.10,0.15,and0.20.Alldiﬀerences
are highly statistically diﬀerent (P<0.001). Lines continue to
diverge with age. The postponement is 8.6 years between groups
in reaching the .010 mark, 12.6 years to reach the 0.15 mark,
and projected at 16.6 years for the HAQ level of 0.20. Consistent
moderately active exercise postpones onset of disability for many
years.
of Morbidity on a national level, in these populations and
over these periods. In all, the seven highest rated US studies
over the same periods had similar reductions in disability,
although most of these did not cover this entire 22-year
period [38–40]. These are the largest, longest, and most
carefully performed studies [38–40]. Even so, they are less
than desirable. The categories of disability are not clearly
deﬁned, the scales are not continuous, and more reliable and
sensitive scales are available [26, 28, 41, 42]. Internationally,
many (usually smaller and shorter) studies have supported
these ﬁndings and some not, and it is diﬃcult to identify
speciﬁc reasons (such as study size, study quality, medical
care quality, health risks, or other factors) for diﬀerences
between studies [40]. Conservatively, we think the positive
results in the best studies provide proof of concept, while
somediscordantresultsinotherpopulationsstronglysuggest
that improvement in age-speciﬁc disability levels over time
is not inevitable. No country has yet enunciated or imple-
mented health policies speciﬁcally directed at Compression
of Morbidity.
9.RandomizedControlledTrialsinSeniors
Thestandardforscientiﬁcproofofconceptisdocumentation
that in randomized controlled trials of theory-based inter-
ventions, the intervention provides better outcomes (e.g.,
greater reduction in disability) than the control intervention.8 Journal of Aging Research
Table 3: US National Long-Term Care Survey (NLTCS): disability categories over time. US population—age 65 and older (%).
Disability category 1982 1989 1994 1999 2004 Overall change Decline per year (%)
Any 26.5 24.8 23.2 21.2 19.0 −28% 1.27
Mild (IADL only) 5.7 4.5 4.4 3.3 2.4 −58% 2.64
Moderate (1-2) 6.8 6.6 6.1 6.3 5.6 −18% 0.82
Very severe (5-6) 3.5 3.1 2.9 3.0 3.2 −9% 0.41
Institutionalized 7.5 6.9 6.3 4.9 4.0 −47% 2.14
Relatively few randomized controlled studies of lifestyle
change interventions in senior populations have been per-
formed. However, RAND developed an evidence report
and evidence-based recommendations for the Center for
Medicare and Medical Services, studying 55 programs
and rejecting a similar number. Results supported further
consideration of Health Risk Appraisal-based programs
and recommended the Senior Risk Reduction Program be
initiated; it is now ongoing [43]. Other in-depth reviews
have yielded similarly positive ﬁndings [44–47]a n dh a v e
recommended implementations on a national scale. There is
much supporting data [48–50].
Speciﬁc studies of successfully well-evaluated programs
showcommonfeaturesandresults[51–56].Programscollect
Health Risk Appraisal (HRA) data, develop individualized
(tailored) reports for each participant, repeat the process
at predetermined intervals, incorporate change reports into
materialsspeciﬁcforeachindividual,andusecomputertech-
niques to develop individualized interventions. Programs
evaluated [57] cost from $6 to $100 per year and have
return-on-investment (ROI) from claims savings of 3.5 to
6.1. Health risks have been reduced 10 to 17 percent over the
ﬁrst 6 to 12 months and claims savings per person range up
to $570 per year.
The Senior Risk Reduction program, now in its third
year, randomly selected 85,000 Medicare recipients aged 67
to 74 and randomly assigned these subjects into two control
and two intervention groups. The intervention groups were
selected as the most promising interventions from previous
studies [43]. Outcomes are being assessed by an independent
group and are expected to be available 2011-2012. A positive
study will save money for Medicare and improve health
outcomes for those in the intervention groups.
10. Closing Comments
Compression of Morbidity is a necessary precedent for
healthieraging,whichinturncompletesavisionofimproved
health throughout the life cycle. Proof of its possibility
comes from study of individuals as they course through
their senior years, national studies of population aging,
and targeted randomized studies of lifestyle interventions
in seniors. These speciﬁc approaches ﬁnd support in a rich
tapestry of physiologic, psychological, biochemical, medical,
and cognitive studies linking lifestyles with health outcomes
which ﬂood over scientiﬁc publications and other news
sources on a daily basis [49, 50].
If we can accomplish morbidity compression without
a strategy, as over the past thirty years, then we should
be able to further improve if we have a plan. We have
identiﬁed solid approaches toward such a plan. A strategy
should have goals of (1) never smoking, no obesity, never
sedentary (Primordial Prevention); the strategy should have
goals of (2) increasing exercise, reducing smoking, reducing
obesity, and also moderating other health risks (Primary
Prevention); (3) within the medical model, goals must
include reduction in cholesterol, hypertension, diabetes,
time to ﬁrst heart attack (Secondary Prevention); (4)
morbidity-reducing interventions, such as total hip and
knee replacements, cataract extractions, and many others
(Tertiary Prevention) must also be part of the strategy.
Electronic medical records, if (and only if) modiﬁed to
systematically collect outcome/morbidity/disability data and
healthriskdata,couldprovideacost-eﬀectivewaytodevelop
the data sets necessary to eﬀectively direct policy. These are
among the immediate targets and will be enunciated again
in the Healthy People 2020 Formulation. There are many
more behind them, together of course with the challenges
of epidemic illness and man’s inhumanity to man. The
Compression of Morbidity paradigm is now a comfortable
and familiar construct and a base from which to assess health
gains and losses.
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